Drug Profile
Ranirestat - Sumitomo Pharma
Alternative Names: AS-3201; SX-3030; SX-3202Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Dainippon Sumitomo Pharma
- Developer Eisai Co Ltd; Sumitomo Pharma
- Class Antihyperglycaemics; Pyrazines; Small molecules; Spiro compounds
- Mechanism of Action Aldehyde reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diabetic neuropathies